Local drug delivery to prevent restenosis

Journal of Vascular Surgery

Volumn 57, Issue 5, 2013, Pages 1403-1414

  Seedial, Stephen M ^a,b   Ghosh, Soumojit ^b   Saunders, R Scott ^b   Suwanabol, Pasithorn A ^b   Shi, Xudong ^b   Liu, Bo ^b   Kent, K Craig ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EVEROLIMUS; MICROSPHERE; PACLITAXEL; RAPAMYCIN;

BALLOON; BARE METAL STENT; CATHETER; CORONARY ARTERY BLOOD FLOW; DRUG DELIVERY SYSTEM; DRUG ELUTING STENT; ENDARTERECTOMY; EUROPE; FEMORAL ARTERY; HUMAN; MEDLINE; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; RESTENOSIS; REVIEW; STENT; SYSTEMATIC REVIEW;

ANIMALS; CARDIAC CATHETERS; CARDIOVASCULAR AGENTS; CORONARY RESTENOSIS; CORONARY STENOSIS; DRUG CARRIERS; DRUG-ELUTING STENTS; ENDOVASCULAR PROCEDURES; EQUIPMENT DESIGN; HUMANS; HYPERPLASIA; NEOINTIMA; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL VASCULAR DISEASES; RECURRENCE; TREATMENT OUTCOME; VASCULAR ACCESS DEVICES;

EID: 84876375233     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2012.12.069     Document Type: Review

References (45)

1. A.W. Clowes, and M.A. Reidy Prevention of stenosis after vascular reconstruction: pharmacologic control of intimal hyperplasia - a review J Vasc Surg 13 1991 885 891
2. A.W. Clowes, M.A. Reidy, and M.M. Clowes Mechanisms of stenosis after arterial injury Lab Invest 49 1983 208 215
3. A.W. Clowes, M.A. Reidy, and M.M. Clowes Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium Lab Invest 49 1983 327 333
4. M. Hamon, E. Lecluse, J.P. Monassier, G. Grollier, and J.C. Potier Pharmacological approaches to the prevention of restenosis after coronary angioplasty Drugs Aging 13 1998 291 301
5. S. Sharma, C. Christopoulos, N. Kukreja, and D.A. Gorog Local drug delivery for percutaneous coronary intervention Pharmacol Ther 129 2011 260 266
6. D.B. Fram, J.F. Mitchel, M.A. Azrin, M.S. Chow, D.D. Waters, and R.G. McKay Local delivery of heparin to balloon angioplasty sites with a new angiotherapy catheter: pharmacokinetics and effect on platelet deposition in the porcine model Cathet Cardiovasc Diagn 41 1997 275 286
7. I. Gradus-Pizlo, R.L. Wilensky, K.L. March, N. Fineberg, M. Michaels, and G.E. Sandusky Local delivery of biodegradable microparticles containing colchicine or a colchicine analogue: effects on restenosis and implications for catheter-based drug delivery J Am Coll Cardiol 26 1995 1549 1557
8. C. Herdeg, M. Oberhoff, A. Baumbach, A. Blattner, D.I. Axel, and S. Schroder Local paclitaxel delivery for the prevention of restenosis: biological effects and efficacy in vivo J Am Coll Cardiol 35 2000 1969 1976
9. D.W. Muller, E.J. Topol, G.D. Abrams, K.P. Gallagher, and S.G. Ellis Intramural methotrexate therapy for the prevention of neointimal thickening after balloon angioplasty J Am Coll Cardiol 20 1992 460 466
10. Z.M. Gertz, and R.L. Wilensky Local drug delivery for treatment of coronary and peripheral artery disease Cardiovasc Ther 29 2011 e54 e66
11. Y.C. Chan, and S.W. Cheng Drug-eluting stents and balloons in peripheral arterial disease: evidence so far Int J Clin Pract 65 2011 664 668
12. C. Stettler, S. Wandel, S. Allemann, A. Kastrati, M.C. Morice, and A. Schömig Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis Lancet 370 2007 937 948
13. S.H. Duda, M. Bosiers, J. Lammer, D. Scheinert, T. Zeller, and V. Oliva Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial J Endovasc Ther 13 2006 701 710
14. J. Lammer, M. Bosiers, T. Zeller, M. Schillinger, E. Boone, and M.J. Zaugg First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease J Vasc Surg 54 2011 394 401
15. M.D. Dake, G.M. Ansel, M.R. Jaff, T. Ohki, R.R. Saxon, and H.B. Smouse Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results Circ Cardiovasc Interv 4 2011 495 504
16. P.W. Serruys, Y. Onuma, J.A. Ormiston, B. de Bruyne, E. Regar, and D. Dudek Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes Circulation 122 2010 2301 2312
17. R. Erbel, C. Di Mario, J. Bartunek, J. Bonnier, B. de Bruyne, and F.R. Eberli Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial Lancet 369 2007 1869 1875
18. A.M. Lincoff, J.G. Furst, S.G. Ellis, R.J. Tuch, and E.J. Topol Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model J Am Coll Cardiol 29 1997 808 816
19. T. Yamawaki, H. Shimokawa, T. Kozai, K. Miyata, T. Higo, and E. Tanaka Intramural delivery of a specific tyrosine kinase inhibitor with biodegradable stent suppresses the restenotic changes of the coronary artery in pigs in vivo J Am Coll Cardiol 32 1998 780 786
20. P.W. Serruys, J.A. Ormiston, Y. Onuma, D. Dudek, L. Thuesen, and M.W. Webster A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods Lancet 373 2009 897 910
21. J. Wohrle Drug-coated balloons for coronary and peripheral interventional procedures Curr Cardiol Rep 14 2012 635 641
22. D.I. Axel, W. Kunert, C. Göggelmann, M. Oberhoff, C. Herdeg, and A. Küttner Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery Circulation 96 1997 636 645
23. G. Tepe, T. Zeller, T. Albrecht, S. Heller, U. Schwarzwälder, and J.P. Beregi Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg N Engl J Med 358 2008 689 699
24. M. Werk, S. Langner, B. Reinkensmeier, H.F. Boettcher, G. Tepe, and U. Dietz Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial Circulation 118 2008 1358 1365
25. D. Brieger, and E. Topol Local drug delivery systems and prevention of restenosis Cardiovasc Res 35 1997 405 413
26. C.R. Lambert, J.E. Leone, and S.M. Rowland Local drug delivery catheters: functional comparison of porous and microporous designs Coron Artery Dis 4 1993 469 475
27. F. Latif, and T.A. Hennebry Successful revascularization of re-stenosis of lower extremity arteries with localized delivery of paclitaxel Catheter Cardiovasc Interv 72 2008 294 298
28. R.C. Siow, and A.T. Churchman Adventitial growth factor signalling and vascular remodelling: potential of perivascular gene transfer from the outside-in Cardiovasc Res 75 2007 659 668
29. E.A. Lipke, and J.L. West Localized delivery of nitric oxide from hydrogels inhibits neointima formation in a rat carotid balloon injury model Acta Biomater 1 2005 597 606
30. M.J. Jung, J.S. Kwon, N.K. Park, Y.K. Kim, T.J. Shim, and I.H. Jeong Perivascular delivery of rapamycin in pluronic gel inhibits neointimal hyperplasia in a rat carotid artery injury model, and the complementary role of carotid arteriography Korean Circ J 38 2008 80 86
31. B. Kelly, M. Melhem, J. Zhang, G. Kasting, J. Li, M. Krishnamoorthy, and S. Heffelfinger Perivascular paclitaxel wraps block arteriovenous graft stenosis in a pig model Nephrol Dial Transplant 21 2006 2425 2431
32. W. Tian, M.T. Kuhlmann, J. Pelisek, S. Scobioala, T.H. Quang, and L. Hasib Paclitaxel delivered to adventitia attenuates neointima formation without compromising re-endothelialization after angioplasty in a porcine restenosis model J Endovasc Ther 13 2006 616 629
33. W.J. Gasper, C.A. Jimenez, K. Seward, M.S. Conte, and C. Owens Peri-adventitial delivery of a nanoparticle albumin-bound (nab) rapamycin reduces luminal stenosis in a porcine femoral artery balloon injury model. Presented at the 2011 Vascular Annual Meeting June 16-18, 2011 Ill Chicago
34. A. De Labriolle, R. Pakala, L. Bonello, G. Lemesle, M. Scheinowitz, and R. Waksman Paclitaxel-eluting balloon: from bench to bed Catheter Cardiovasc Interv 73 2009 643 652
35. T.E. Deglau, T.M. Maul, F.S. Villanueva, and W.R. Wagner In vivo PEG modification of vascular surfaces for targeted delivery J Vasc Surg 55 2012 1087 1095
36. J.M. Chan, J.W. Rhee, C.L. Drum, R.T. Bronson, G. Golomb, and R. Langer In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid-polymeric nanoparticles Proc Natl Acad Sci U S A 108 2011 19347 19352
37. M. Bosiers, C. Cagiannos, K. Deloose, J. Verbist, and P. Peeters Drug-eluting stents in the management of peripheral arterial disease Vasc Health Risk Manag 4 2008 553 559
38. C. Herdeg, M. Oberhoff, A. Baumbach, A. Blattner, D.I. Axel, and S. Schröder Local paclitaxel delivery for the prevention of restenosis: biological effects and efficacy in vivo J Am Coll Cardiol 35 2000 1969 1976
39. M.W. Krucoff, D.J. Kereiakes, J.L. Petersen, R. Mehran, V. Hasselblad, and A.J. Lansky A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study J Am Coll Cardiol 51 2008 1543 1552
40. Y. Huang, S.S. Venkatraman, F.Y. Boey, E.M. Lahti, P.R. Umashankar, and M. Mohanty In vitro and in vivo performance of a dual drug-eluting stent (DDES) Biomaterials 31 2010 4382 4391
41. A. Micari, A. Cioppa, G. Vadalà, F. Castriota, A. Liso, and A. Marchese Clinical evaluation of a paclitaxel-eluting balloon for treatment of femoropopliteal arterial disease: 12-month results from a multicenter Italian registry JACC Cardiovasc Interv 5 2012 331 338
42. A. Schmidt, M. Piorkowski, M. Werner, M. Ulrich, Y. Bausback, and S. Bräunlich First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome J Am Coll Cardiol 58 2011 1105 1109
43. M.C. Moon, K. Molnar, L. Yau, and P. Zahradka Perivascular delivery of losartan with surgical fibrin glue prevents neointimal hyperplasia after arterial injury J Vasc Surg 40 2004 130 137
44. L.P. Yau, P. Molnar, M.C. Moon, S. Buhay, J.P. Werner, and K. Molnar Meta-iodobenzylguanidine, an inhibitor of arginine-dependent mono(ADP-ribosyl)ation, prevents neointimal hyperplasia J Pharmacol Exp Ther 326 2008 717 724
45. J. Margolis, J. McDonald, R. Heuser, P. Klinke, R. Waksman, and R. Virmani Systemic nanoparticle paclitaxel (nab-paclitaxel) for in-stent restenosis I (SNAPIST-I): a first-in-human safety and dose-finding study Clin Cardiol 30 2007 165 170